FibroBiologics Amends Bylaws to Align with Universal Proxy Rules and DGCL Updates

FibroBiologics, Inc.

Amended bylaws adopted June 25, 2024, clarifying procedural requirements under Rule 14a-19 universal proxy rules.
Requires stockholders soliciting proxies to use a proxy card color other than white.
Raised threshold for stockholder amendments of bylaws to 66 2/3% to align with the Certificate of Incorporation.
Removed inconsistent provisions including ability of majority stockholders to remove directors without cause and call special meetings.
Eliminated duplicative and obsolete provisions such as stock transfer restrictions from the direct listing.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.